4592 SanBio Company LimitedサンバイオTSE Growth / Pharmaceuticals
0 posts
SanBio Company Limited (4592) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
SanBio Company Limited (4592) Stock Price HistoryNear a 52-week low
SanBio Company Limited closed at ¥738 on Nov 20, 2026, −19.8% over 1 month, −68.5% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥80,217 today (−19.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −19.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥738 | −61 | −7.63% |
| Nov 19 (Thu) | ¥799 | −9 | −1.11% |
| Nov 18 (Wed) | ¥808 | +0 | +0.00% |
| Nov 17 (Tue) | ¥808 | −26 | −3.12% |
| Nov 16 (Mon) | ¥834 | −8 | −0.95% |
| Nov 13 (Fri) | ¥842 | −6 | −0.71% |
| Nov 12 (Thu) | ¥848 | −14 | −1.62% |
| Nov 11 (Wed) | ¥862 | +1 | +0.12% |
| Nov 10 (Tue) | ¥861 | +31 | +3.73% |
| Nov 9 (Mon) | ¥830 | +36 | +4.53% |
If you had invested ¥100,000 3 months ago, it would be worth ¥70,825 today (−29.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −29.2%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥738 | −61 | −7.63% |
| Nov 19 (Thu) | ¥799 | −9 | −1.11% |
| Nov 18 (Wed) | ¥808 | +0 | +0.00% |
| Nov 17 (Tue) | ¥808 | −26 | −3.12% |
| Nov 16 (Mon) | ¥834 | −8 | −0.95% |
| Nov 13 (Fri) | ¥842 | −6 | −0.71% |
| Nov 12 (Thu) | ¥848 | −14 | −1.62% |
| Nov 11 (Wed) | ¥862 | +1 | +0.12% |
| Nov 10 (Tue) | ¥861 | +31 | +3.73% |
| Nov 9 (Mon) | ¥830 | +36 | +4.53% |
If you had invested ¥100,000 6 months ago, it would be worth ¥51,645 today (−48.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −48.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥738 | −19.5% |
| Oct 2026 | ¥917 | −4.9% |
| Sep 2026 | ¥964 | −0.6% |
| Aug 2026 | ¥970 | +5.5% |
| Jul 2026 | ¥919 | −7.9% |
| Jun 2026 | ¥998 | −30.1% |
| May 2026 | ¥1,428 | −23.8% |
If you had invested ¥100,000 1 year ago, it would be worth ¥31,525 today (−68.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −68.5%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥738 | −19.5% |
| Oct 2026 | ¥917 | −4.9% |
| Sep 2026 | ¥964 | −0.6% |
| Aug 2026 | ¥970 | +5.5% |
| Jul 2026 | ¥919 | −7.9% |
| Jun 2026 | ¥998 | −30.1% |
| May 2026 | ¥1,428 | −23.8% |
| Apr 2026 | ¥1,875 | +5.3% |
| Mar 2026 | ¥1,781 | −21.1% |
| Feb 2026 | ¥2,258 | +22.1% |
| Jan 2026 | ¥1,849 | +9.4% |
| Dec 2025 | ¥1,690 | −23.4% |
| Nov 2025 | ¥2,205 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥134,918 today (+34.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved +34.9%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥738 | −56.3% |
| 2025 | ¥1,690 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥68,144 today (−31.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −31.9%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥738 | −56.3% |
| 2025 | ¥1,690 | ― |
If you had invested ¥100,000 in May 2015, it would be worth ¥41,601 today (−58.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +178.9%, while this stock moved −58.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥738 | −56.3% |
| 2025 | ¥1,690 | +125.0% |
| 2024 | ¥751 | +7.0% |
| 2023 | ¥702 | −10.9% |
| 2022 | ¥788 | −21.7% |
| 2021 | ¥1,007 | −24.7% |
| 2020 | ¥1,337 | −49.2% |
| 2019 | ¥2,633 | −67.5% |
| 2018 | ¥8,110 | +151.5% |
| 2017 | ¥3,225 | +150.6% |
| 2016 | ¥1,287 | +24.3% |
| 2015 | ¥1,035 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from May 2015). Please check the latest prices before trading.
SanBio Company Limited (4592) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of SanBio Company Limited (4592)
Business overview
The company is a regenerative medicine business that researches, develops, manufactures and sells cell therapy products in Japan and the US. It targets central nervous system diseases with high unmet needs, such as chronic traumatic brain injury, chronic stroke, age-related macular degeneration and Parkinson's disease. Its basic model is licensing development and sales rights to drug makers, while it also plans to obtain approval and sell products itself.
Summarized from the annual securities report (fiscal year ended January 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 5.03x | Above the sector median of 1.86x (No. 66 from the lowest) |
|---|---|---|
| ROE | -44.81% | No. 44 in the sector (highest first); median 4.17% |
| Market cap | ¥57.6 bn | No. 30 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥2,390 | 2/19 |
|---|---|---|
| 52-week low | ¥738 | 11/20 |
| Current position | 0.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥738) |
| Year to date | -56.3% | No. 74 of 77 in the sector (best first) |
| 1 year | -68.5% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 2 times | Latest: 10/9 (No. 9) |
|---|---|---|
| Top 50 losers | 2 times | Latest: 10/19 (No. 23) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 10/30 15:30株式会社りそな銀行とのコミットメントライン契約の締結および借入枠の拡大について
- 09/14 15:302027年1月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
- 09/14 15:302027年1月期第2四半期累計期間の連結業績予想と実績値との差異に関するお知らせ
Filings from the past 12 months (3).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the SanBio Company Limited board
More Japanese stocks in English
- HEALIOS K.K.4593
- BrightPath Biotherapeutics Co.,Ltd.4594
- MIZUHO MEDY CO.,LTD.4595
- Kubota Pharmaceutical Holdings Co.,Ltd.4596
- Solasia Pharma K.K.4597
- Delta-Fly Pharma,Inc.4598
- StemRIM Inc.4599
- Nomura High-yield J-REIT Index ETF459A
- BRANU Inc.460A
- Dai Nippon Toryo Company,Limited4611
- NIPPON PAINT HOLDINGS CO.,LTD.4612
- KANSAI PAINT CO.,LTD.4613